Sleeve lobectomy for non-small cell lung cancer
10.7507/1007-4848.201711078
- VernacularTitle:袖式肺叶切除术在非小细胞肺癌中的应用
- Author:
PAN Maojie
1
;
WEI Yucheng
1
Author Information
1. Department of Thoracic Surgery, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, P.R.China
- Publication Type:Journal Article
- Keywords:
Non-small cell lung cancer;
sleeve lobectomy;
neoadjuvant therapy;
lymph nodes staging;
minimally invasive procedure
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2018;25(6):526-532
- CountryChina
- Language:Chinese
-
Abstract:
Surgery has remained the cornerstone of lung cancer therapy. Sleeve lobectomy, which is featured by not only the maximal resection of tumors but also the maximal preservation of functional lung parenchyma, has been proved to be a valid therapeutic option for the treatment of some centrally located lung cancer . Evidence points toward equivalent oncologic outcomes with improved survival and quality of life after sleeve resections compared with pneumonectomy. However, the postoperative morbidities and the long-term results after sleeve lobectomy remain controversial, especially in relation to nodal involvement and after induction therapy. With the development of technology, minimally invasive procedures have been performed more and more widely.
